News | May 20, 2008

Remote Interrogation Detects Events Earlier in Pacemaker Patients

May 21, 2008 - Physicians can detect and diagnose clinically actionable events earlier in pacemaker patients who utilize remote interrogation compared to those that are followed via routine office visits augmented by transtelephonic monitoring (TTM), according to the PREFER Trial, a late-breaking clinical trial presented at Heart Rhythm 2008, the Heart Rhythm Society’s 29th Annual Scientific Sessions.

The PREFER Trial is the first to compare remote monitoring diagnosis rates to diagnosis rates using traditional pacemaker follow-up. The prospective, randomized trial analyzed data from 897 patients from 50 centers throughout the United States. At enrollment, patients were randomized 2:1 to have pacemaker follow-up by a combination of in-person programming evaluations augmented by either remote interrogation or transtelephonic rhythm strip evaluations. At each follow-up visit or scheduled transmission, physicians reviewed the available data for pre-specified clinically actionable events.

“With current pacemaker systems continuously recording clinical information, clinicians now have robust and objective data to diagnose clinical events. However, this information is only valuable if providers can access it in a timely manner that enables clinical intervention before the event progresses,” said lead author Bruce L. Wilkoff, MD, FHRS, Director of Cardiac Pacing and Tachyarrhythmia Devices at the Cleveland Clinic and chair of the Heart Rhythm Society’s Health Policy Committee. “Internet-based remote monitoring tools now make it possible for clinical information to reach physicians with minimal intrusiveness for both the patient and the clinician.”

At the end of the 12 month trial, results showed that clinically actionable events are detected earlier in patients that used remote interrogation instead of TTM monitoring. Overall, less than 2 percent of events were detected by remote transmission in patients using TTM monitoring, while more than 60 percent were detected in the patient group that used remote interrogation.

For more information:

Related Content

Mexican Doctors Safely Reuse Donated Pacemakers After Sterilization

Mexican government reports conclude more than half of the population does not have access to social security or private insurance that covers a pacemaker implant, and 44 percent live in poverty. Recycling donated, explanted pacemakers offers a new option for these patients.

News | Pacemakers| November 10, 2017
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
closed loop stimulation, DDD-CLS, ACC17, SPAIN trial
Feature | Pacemakers| March 22, 2017
March 22, 2017 — Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing pro
Micra leadless pacemaker, CMS, medicare reimbursement
News | Pacemakers| March 10, 2017
March, 10, 2017 - Medtronic announced that the U.S.
Medtronic, Micra TPS pacemaker, transcatheter pacing system, global clinical trial, one-year results, ESC 2016
News | Pacemakers| August 29, 2016
August 29, 2016 — Medtronic plc announced new long-term results from the Medtronic Micra Transcatheter Pacing System
Medtronic, Micra TPS pacemaker, Global Clinical Trial, Cardiostim 2016
News | Pacemakers| June 09, 2016
Medtronic plc announced new results from the Medtronic Micra Transcatheter Pacing System (TPS) Global Clinical Trial in...
Medtronic, Micra TPS, transcatheter pacing system, pacemaker, Jersey Shore University Medical Center, New Jersey first
News | Pacemakers| June 06, 2016
Jersey Shore University Medical Center, part of Meridian CardioVascular Network, is the first hospital in New Jersey to...
Overlay Init